Ion Exchange India Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is CHOLESTYRAMINE RESIN USP (INDION 454), with a corresponding US DMF Number 23171.
Remarkably, this DMF maintains an Active status since its submission on October 05, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 06, 2014, and payment made on September 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II